Opus Genetics IRD
NASDAQ IRD
$3.82 -0.29 (-7.06%)
At close: Oct 22, 2026 · 4:00 PM EDT

Opus Genetics (IRD) Amortization of Deferred Charges (2020)

Updated

Analysis

Opus Genetics (IRD) Amortization of Deferred Charges (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,140.21 Bn 1,108.80 Bn 19.71 Bn
2 Johnson & Johnson 632.33 Bn 552.19 Bn 17.30 Bn
3 AbbVie 500.02 Bn 473.13 Bn 12.70 Bn
4 Merck 355.31 Bn 309.69 Bn 12.21 Bn
5 Novartis Ag 300.67 Bn 264.66 Bn 11.24 Bn
6 Astrazeneca 263.56 Bn 237.25 Bn 12.86 Bn
7 Amgen 237.81 Bn 193.20 Bn 7.24 Bn
8 Gilead Sciences 194.42 Bn 168.61 Bn 6.22 Bn
9 Pfizer 171.28 Bn 117.93 Bn 10.94 Bn
10 Opus Genetics 352.33 Mn 127.62 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 -1,000.00
Sep 30, 2020 9,000.00
Jun 30, 2020 489,000.00
Mar 31, 2020 376,000.00
API Access

Opus Genetics Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=IRD&period=max&api_key=YOUR_API_KEY